엉겅퀴로부터 분리한 Silymarin 및 Silybin이 Macrophages에 의한 사람 Low Density Lipoprotein의 산화에 대한 항산화 효과

  • 발행 : 1997.06.01

초록

This study was undertaken to evaluate an antioxidative activity of silymarin and silybin obtained from Silybum marianum against oxidation of human low density lipoprotein (LDL). The electrophoretic mobility observed apparently was higher phase for LDL oxidized by macrophages compared to native LDL. Silymarin and silybin inhibited the copper-catalysed oxidation of human LDL in a dose-dependent manner. Silymarin and silybin at the concentration of 50 $\mu$M/ml also inhibited the copper catalysed oxidation of LDL induced by the cell J774 and macrophages. LDL reisolated from the cell incubation in the presence of silymarin or silybin was degraded at rates similar with native LDL. Silymarin or silybin found to be potential inhibitors against oxidation of $^{125}$I-LDL by macrophages and endothelial cells.

키워드

참고문헌

  1. The flavonoids Harborne, J. B.;T. J. Mabry;H. Mabry
  2. J. Food Technol. v.11 Flavonols and flavones in plants. A review Herrmann, K.
  3. World Rev. Nutr. Diet. v.24 The flavonoids. A class of semi-essential food components. Their role in human nutrition Kuhnau, J.
  4. Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships Flavonoids in the human diet Pierpoint, W. S.
  5. Plant Flavonoids in Biology and Medicine Ⅱ. Biochemical, Cellular, and Medicinal Properties Crystal and molecular structure of flavonoids Cody, V.
  6. the Flavonoids. Advances in Research Since 1986 The impact of plant flavonoids on memmalian biology. Implications for immunity, inflammation and cancer Middleton, E., Jr.;C. Kandswami;J.B. Harborne(ed.)
  7. Biochem. Med. Metabol. Biol. v.39 Effects of flavonoids on nonenzymic lipid peroxidation. Structure activity relationship Ratty, A. K.;N. P. Das
  8. Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships The metabolism of flavonoid compounds in mammals Hackett, A. M.
  9. Flavonoids in biology and medicine Ⅲ-Curent issues in flavonoids research Das, N. P.(ed.)
  10. Adv. Exp. Med. Biol. v.366 Middleton, E. Free radical scavenging and antioxidant activity of plant flavonoids Kandaswami, C.
  11. J. Natl. Prod. v.53 Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells Nonaka, G.;L. Nishioka;M. Nishizawa;T. Yamagishi;Y. Kashiwada;G. E. Dutschman;A. J. Bodner;R. E. Kilkuskie;Y.-C. Cheng;K.-H. Lee
  12. Biochemistry v.29 Differential inhibitory effects of some catechin derivatives on the activities of human immunodefieiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases Nakane, H.;K. Ono
  13. Biochem. Pharmacol. v.43 Effests of flavonoids on immune and inflammatory functions Middleton, E.;C. Kandaswami
  14. FEBS Lett. v.329 Caffeic acid phenethyl ester as a lipoxygengenase inhibitor with antioxidant properties Sudina, G. F.;O. K. Mirzoeva;M. A. Pushkareva;G. A. Korshunova;N. V. Sumbutya;S. D. Varfolomeev;
  15. Prev. Med. v.21 Antioxidative effect of polyphenol extract prepared from various chinese teas Ho, C.-T.;Q. Chen;H. Shi;K.-Q. Zhang;R. T. Rosen
  16. Food Technol. April: 85-8 Possible mechanisms for the protective role of antioxidants in wine and plant foods Kinsella, J. E.;E. Frankel;B. German;J. Kanner
  17. Crit. Rev. Food Sci. Nutr. v.29 Antioxidants/antimutagens in food Namiki, M.
  18. 한국식 품과학회지 v.28 사람 LDL 수식에 의한 녹차의 항산화활성 박춘옥;류병호
  19. New Engl. J. Med v.320 Modification of low-density lipoprotein that increases its atherogenicity Steinberg, D.;S. Parthasarathy;T. E. Carew;J. C. Khoo;J. L. Witztum
  20. Biochim. Biophy. Acta. v.1257 Association of megatively-charged phospholipids with low density lipoprotein (LDL) increasesit uptake and the deposition of cholesteryl esters by macrophages Greenspan, P.;B. H. Ryu;F. Mao;R. L. Gutman
  21. Nature. v.362 The pathogenesis of atherosclerosis: perspective for the 1990'S Ross., R.
  22. N. Engl. J. Med. v.320 Witztum Beyond cholesterol. Modifications of lowdensity lipoprotein that increases its atherogenicity Steinberg D.;Parthasarathy S.;Carew T. E.;J. C Khoo;J. L. Witztum
  23. Chem. Res. Toxicol. v.3 Biochemical, structural and functional properties of oxidized low-density lipoprotein Esterbauer, H.;M. Dieber-Rotheneder;G. Waeg;G. Striegl
  24. Biochim. Bioph. Acta v.1301 Iron-ascorbate-phospholipiu mediated modification of low density lipoprotein Greenspan, P.;R. L. Gutman;F. Mao;B. H. Ryu;P. Low
  25. Klin Wochenschr. v.69 Oxygen radicals and atherosclerosis Carpenter, K. L. H.;C. E. Brabbs;M. J. Mitchinson
  26. Proc. Natl. Acad. Sci., USA v.78 Enhanced macrophage degradation of low density lipoportein previously incubated with cultured endothelial cells. Recognition by the receptor for acetylated low density lipoprotein Henriksen, T.;E. Mahoney;D. Steinberg
  27. Arteriosclerosis. v.3 Enhanced macrophage degradation of biologically modified low density lipoprotein Henriksen, T.;E. M. Mahoney;D. Steinberg
  28. Arterloscerosis v.4 Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation Morel, D. W.;P. E. Docorleto;G. M. Chisolm
  29. Biosci. Biotech. Biochem. v.59 Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein Ryu, B. H.;F. W. Mao;P. Lou;R. L. Gutman;P. Greenspan
  30. J. Clin. Invest. v.74 Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture Heinecke, J. W.;H. Rosen;A. Chait
  31. Proc. Natl. Acad. Sci., USA v.83 Modification of low density lipoprotein by endothelial cells nvolves lipid peroxidation and degradation of low density lipoprotein phospholipids Steinbrecher U.;S. Parthasarathy;D. S. Leake;J. L. Witztum;D. Steinberg
  32. Curr. Opin. Lipidol. v.1 Free radicals, lipid peroxidation and atherosclerosis Bruckdorfer, K. R.
  33. Am. J. Clin. Nutr. v.53 Role of vitamin E in preventing the oxidation of low-density lipoprotein Esterbauer H.;H. Puhl;M. Dieber-Rotheneder;G. Striegl;G. Waeg
  34. Artheriosclerosis v.9 Antioxidant activity of probucol and vitamin E(α-tocopherol) in plasma Mao, S. J. T.;M. T. Yates
  35. Ann. N. Y. Acad. Sci. v.570 The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins Esterbauer, H.;G. Streigel;H. Puhl;S. Oberreither;M. Rotherneder;M. El-Saadani;G. Urgens
  36. Biochem. Pharmacol. v.43 The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid Mangiapane, H.;J. Thomson;A. Salter;S. Brown;G. D. Bell;D. A. White
  37. Biochem. Pharmacol. v.39 Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages De Whalley, C. V.;S. M. Rankin;J. R. S. Hoult;W. Jessup;D. S. Leake
  38. FASEB J. v.1 Free radical tissue damage: Protective role of antioxidant nutrients Machlin, L. J.;A. Bendich
  39. Scand. J. Gastroenterol. v.17 Effect of silymarin on chemical, functional, and morphological alterations of the liver Salmi, H. A.;S. Sarna
  40. Arzneimitteforsch v.23 Die Antihepatotoxische Wirkung von parenteral verabreichtem silymarin bei der Leberchadigung der Ratte durch CCI₄ Rauen, H. M.;H. Schriewer
  41. Arzneimitteforsch v.21 Die antihepatotoxische Wirkung von SIlymarin bei experimentellen Leberchadigung der Ratte durch Tatrachlorkohlen stoff, D-Galaktosamin und Allylalkohol. Rauen, H. M.;H. Schriewer
  42. Fund. Clin. Pharmacol. v.3 Prevention of CCI₄-induced cirrhosis by silymarin Mourelle, M.;P. Murrel;L. Favari;T. Franco
  43. J. Hepatol v.9 Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver Ferenci, P;B. Dragosics;H. Dittrich;H. Frank;L. Benda;H. Lochs;S. Meryn;W. Base;B. Schneider
  44. Planta Med. v.50 Antihepatotoxic actions of flavonolignans from Silybum marianum fruits Nikino, N.;Y. Kiso;H. Wagner;M. Fiebig
  45. J. Appl. Toxicol. v.10 Prevention by silymarin of membrance alterations in acute CCI₄ liver damage Muriel, P.;M. Mourelle
  46. 경성대학교 박사학위논문 엉겅퀴에서 정제한 silymarin 및 silybin의 항산화 효과 이백천
  47. J. Clin. Invest. v.34 The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum Havel, R. J.;H. A. Eder;J. H. Bragdon
  48. J Clin. Invest. v.52 Culture of human endothelial cells derived from umbilical veins Jaffe, E. A.;R. L. Nackman;C. G. Becker;C. R. Minick
  49. Arteriosclerosis v.3 Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins Van Hinsberg, V. W. M.;I. Havekes;J. J. Eneis;E. Van Corven;M. Scheffer
  50. Methods Enzymol. v.108 Methods for the collection of peritoneal and alvaela macrophages McCorron, R. M.;D. K. Goroff;J. E. Luhr;M. A. Murphy;H. B. Herscowitz
  51. Nature v.182 Efficient trace-labeling of proteins with iodide Mac Farland, A. S.
  52. Free Rad. Res. Commun. v.6 Continous monitoring of in vitro oxidation of human low density lipoprotein Esterbauer, H.;G. Striegl;H. Puhl;M. Rotheneder
  53. Biochem., Med. v.15 A simple fluorometric assay for lipoperoxide in blood plasma Yaki, K.
  54. Electrophoresis v.14 Detection by nile red of agarose gel electrophoresed native and modified low density lipoprotein Greenspan, P.;JR. L. Gutman
  55. J. Biol. Chem. v.193 Protein measurement with the Folin phenol reagent. Lowry, O. H.;N. J. Rosebrough;A. L. Farr;R. J. Randell
  56. Carcinogenesis v.10 Prevention of cytotoxicity and ingibition of intracellalar communication by antioxidant catechins isolated from chinese green tea Ruch, R. J.;S. J. Cheng;J. E. Klauning
  57. Current optin. Lipidologe. v.3 Antioxidants and atherosclerosis Jiala, I.;C. Scaccini
  58. J. Lipid Res. v.32 Evidence for a dominant role of lipoxygenase(5) in the oxidation of low density lipoprotein by mouse peritoneal macrophage Rankin, S. M.;S. Parthasarathy;D. Steinberg
  59. Free Rad. Biol. med. v.14 Probucol as an antioxidant and antiatherogenic drug Kuzuga, M.;F. Kuzuza